ATUALIZAÇÃO DO DIAGNÓSTICO, CLASSIFICAÇÃO E TRATAMENTO PARA DIABETES MELLITUS (DM)

Autores

  • Eder de Carvalho Pincinato UNINOVE (SP) e UNICASTELO (SP)

DOI:

https://doi.org/10.13037/rbcs.vol1n1.497

Palavras-chave:

diabetes, tratamento, classificação.

Resumo

Nos últimos anos, com o avanço científico e tecnológico,

novos mecanismos relacionados à etiogenopatia

do diabetes mellitus foram elucidados. Uma das

conseqüências baseadas na nova classificação da

etiologia e patogenia foi desenvolvida pela American

Diabetes Association (1997). Conseqüentemente,

novos métodos de diagnóstico e valores referencias

foram definidos. Assim, esse estudo discutirá a nova

definição, classificação e critérios de diagnóstico

laboratorial e tratamento do diabetes mellitus.

Downloads

Referências

1. National Diabetes Data Group. Classification and diagnosis

of diabetes mellitus and other categories of glucose

intolerance. Diabetes 1979; 28:1039-1057.

2. The Expert Committee on the Diagnosis and Classification

of Diabetes Mellitus: Report of the expert committee on the

diagnosis and classification of diabetes mellitus. Diabetes

Care 2002; 235 Suppl. 1:S5-S20.

3. Sociedade Brasileira de Diabetes. Diagnóstico e

classificação do diabetes mellitus e tratamento do diabetes

mellitus tipo 2. Disponível em: www.diabetes.org.br/

consenso/index.html. Acesso em: 25 de julho de 2002.

4. KAHN, S.E. Beta cell failure: causes and consequences.

Int J Clin Pract Suppl 2001; (123):13-8.

5. HUNTER S.J.; GARVEY, W.T. Insulin action and insulin

resistance: diseases involving defects in insulin receptors,

signal transduction, and the glucose transport effector

system. Am J Med 1998; 105(4):331-45.

6. Sociedade Brasileira de Diabetes. Detecção e tratamento

das complicações crônicas do diabetes mellitus. Disponível

em: www.diabetes.org.br/Diabetes/compcron.html. Acesso

em: 25 de julho de 2002.

7. ATKINSON, M.A.; MADAREN, N.K. The pathogenesis of

insulin dependent diabetes. N Engl J Med 1994;

331:1428-1436.

8. ZIMMET, P.Z.; TUOMI,T; MACKAY, I.R.; ROWLEY, M.J.;

KNOWLES, W.; COHEN, M.; LANG, D.A. Latent

autoimmune diabetes mellitus in adults (LADA): the role of

antibodies to glutamic acid decarboxylase in diagnosis and

prediction of insulin dependency. Diabet Med 1994;

11(3):299-303.

9. REAVEN, G.M.; BERNSTEIN, R.; DAVIS, B.; OLESFSKY, J.M.

Nonketotic diabetes mellitus: insulin deficiency or insulin

resistance? Am J Med 1976; 60(1):80-8.

10. OLEFSKY, J.M.; KOLTERMAN, O.G.; SCARLETT, J.A. Insulin

action and resistance in obesity and noninsulin-dependent

type II diabetes mellitus. Am J Physiol 1982; 243(1):E15-30.

11. DE FRONZO, R.; DEIBERT, D.; HENDLER, R.; FELIG, P.;

SOMAN, V. Insulin sensitivity and insulin binding to

monocytes in maturity-onset diabetes. J Clin Invest

1979; 63(5):939-46.

12. TURNER, R.C.; HOLMAN, R.R.; MATTHEWS, D.;

HOCKADAY, T.D.; PETO, J. Insulin deficiency and insulin

resistance interaction in diabetes: estimation of their relative

contribution by feedback analysis from basal plasma insulin

and glucose concentrations. Metabolism 1979;

28(11):1086-96.

13. JONES, C.W. Gestational diabetes and its impact on the

neonate. Neonatal Netw 2001; 20(6):17-23.

14. VERMA, A.; BONEY, C.M.; TUCKER, R.; VOHR, B.R.

Insulin resistance syndrome in women with prior history of

gestational diabetes mellitus. J Clin Endocrinol Metab

2002; 87(7):3227-35.

15. REICHELT, A.J.; SPISCHLER, E.R.; BRANCHTEIN, L. et al.

Fasting plasma glucose is a useful test for the detection of

gestational diabetes. Diabetes Care 1998; 21:1246-

1249.

16. The Expert Committee on the Diagnosis and Classification

of Diabetes Mellitus. Report of the Expert Committee on

the Diagnosis and Classification of Diabetes Mellitus.

Diabetes Care 1997; 20:1183.

17. GORUS, F.K.; GOUBERT, P.; SEMAKULA, C.;

VABDEWALLW, C.L.; DESCHEPPER, J.; SCHEEN, A. IA-2

autoantibodies in new-onset iddm patients help predict

impending diabetes in their siblings. Diabetologia

1997; 40(1):95-99.

18. CHRISTIE, M.R.; ROLL, U.; PAYATON, M.A.; HATFELD,

E.C.I.; ZIEGLER, A.G. Validity of screening for individuals

at risk for type 1 diabetes by combined analysis of

antibodies to recombinant proteins. Diabetes Care

1997; 20 (6):965-970.

19. ZERBINI, G.; BAZZIGALUPPI, E.; MANGILI, R.; BOSI, E.;

BONIFACIO, E. Prevalence of GAD(65) and IA-2

autoantibodies in IDDM patients affected by diabetic

nephropathy. Diabetologia 1997; 40 (4) 485.

20. SEISSLER, J.; MORGENTHALER, N.G.; ACHENBACH, P.;

LAMPETER, E.F.; GLAVE, D.; PAYTON, M.; et al.

Combined screening for autoantibodies to glutamic acid

descarboxylase in first degree relatives of patients with

IDDM. Diabetologia 1996; 39(11):1351-1356.

21. MOHN, A.; DUNGER, D.B.; CHIARELLI, F. The potential

role of insulin analogues in the treatment of children and

adolescents with Type 1 diabetes mellitus. Diabetes Nutr

Metab 2001; 14(6):349-57.

22. MONH, A.; DUNGER, D.B.; CHIARELLI, F. The potential

role of insulin analogues in the treatment of children and

adolescents with Type 1 diabetes mellitus. Diabetes Nutr

Metab 2001; 14(6):349-57.

23. LIU, E.H.; HEROLD, K.C. Transplantation of the islets of

Langerhans: new hope for treatment of type 1 diabetes

mellitus. Trends Endocrinol Metab 2000; 11(9):379-

82.

24. HEINEMANN, L.; PFUTZNER, A.; HEISE, T. Alternative

routes of administration as an approach to improve insulin

therapy: update on dermal, oral, nasal and pulmonary

insulin delivery. Curr Pharm Des 2001;7(14):1327-51.

25. YAMAOKA, T. Gene therapy for diabetes mellitus. Curr

Mol Med 2001; 1(3):325-37.

AFIA

Downloads

Publicado

2010-04-08

Edição

Seção

ARTIGOS DE REVISÃO

Artigos Semelhantes

1 2 3 4 5 6 7 8 9 10 > >> 

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.